It looks like your language preference is English, switch to GB website?
Update your location to view content relevant to your location.

In the News

What’s new in the world of Allen Carr’s Easyway and cannabis cessation

All Articles

44 items

Goody Two Shoes - Don't drink - don't smoke -...

The issue of copyright theft

ASH Apologises For Unfounded Comments

Today Action on Smoking and Health (ASH), the public health charity has apologised to Allen Carr’s Easyway Organisation for unfounded comments made by its Director in November 2006.

Allen Carr's Easyway Clinics Feature in BBC's REAL STORY

A Message to Friends by Allen Carr

I have been deeply touched by the numerous and encouraging messages of loyalty and support that I have received from you following the announcement of my having contracted lung cancer.

Irish Study Into Most Effective Way To Quit Smoking

Allen Carr’s Easyway is taking part in a clinical trial in Dublin, Ireland to asses our overall success rate in comparison to Irish Health authorities.

Britain votes to leave EU

It's a beautiful, exciting, and wonderful world.

Do we do drugs?

When Allen Carr first interviewed me – way back in 1998 – he looked through my résumé and remarked that it didn’t really tell him what he wanted to know...

“Not so” Legal Highs: Spice, Mamba, K2 and many more

The situation regarding ‘legal highs’ has not been resolved by their criminalisation. They are cheap and marketed as if they are harmless recreational drugs. #QuitDrugs #DrugAddiction

THE BRITS HAVE LANDED!

Allen Carr’s Easyway is delighted to announce the launch of stop smoking clinics as a franchise offering in the USA for the first time.

Spice: The Scourge of London

What is Spice? What are the symptoms of addiction? Why is it now the scourge of London, Los Angeles, New York, and Tokyo?

10th Anniversary of Allen Carr's Death

Far from losing momentum following his death, the organisation that survives Allen Carr has gone from strength to strength, driven by his loyal team of close friends, family, and colleagues.